Patent 10138488 was granted and assigned to Invectys on November, 2018 by the United States Patent and Trademark Office.
The present invention provides an immunogenic composition comprising a nucleic acid that comprises a sequence encoding a dog telomerase deprived of telomerase catalytic activity, or a fragment thereof.